Influenza
Conditions
Interventions
Intervention name: Telemedicine for influenza following positive self-administered test Intervention details: Among patients with influenza-like illness who obtain a positive result on a self-adminis
Sponsors
Hamamtsu University School of Medecine
Hamamatsu Medical Center
Eligibility
Sex/Gender
All
Inclusion criteria
Inclusion criteria: Telemedicine Group Age 18 to less than 65 years. Residence in the pre-reorganization wards of Hamamatsu City: former Naka, Higashi, Nishi, Minami, or Kita Ward. No risk factors for severe influenza: none of the following (pregnancy, underlying comorbidities, BMI >= 30, current smoking). Able to perform a combined COVID-19 and influenza rapid antigen self-test after onset of influenza-like illness. Willing to receive telemedicine during the designated hours if the self-test is positive for influenza. Agrees to online consultation via the CLINICS app and to online medication counseling. Has or can obtain a Hamamatsu Medical Center patient ID. Provides written informed consent after understanding the study purpose. Historical In-Person Group Visited the Hamamatsu Medical Center after hours during Dec 1, 2017 - Mar 31, 2018 or Dec 1, 2018 - Mar 31, 2019. Age 18 to less than 65 years. Diagnosed with influenza based on a positive rapid antigen test at the index visit. Registered address at the time of visit within the pre-reorganization wards of Hamamatsu City: former Naka, Higashi, Nishi, Minami, or Kita Ward. No risk factors for severe influenza: none of the following (pregnancy, underlying comorbidities, BMI >= 30, current smoking).
Exclusion criteria
Exclusion criteria: Telemedicine Group Patients meeting any of the following will be excluded: Do not possess the devices/equipment necessary to receive telemedicine. Despite fever or influenza-like symptoms, have strong anxiety about telemedicine and strongly prefer in-person consultation at a medical facility. Lack an environment that ensures privacy for receiving telemedicine. Have previously experienced major disadvantages or troubles related to telemedicine (e.g., communication failures, misdiagnosis, prescription errors). Have plans for long-term business trips or travel, making continuous contact and follow-up during the study period difficult. Report strong psychological stress or anxiety specifically regarding participation in the study. Have cognitive impairment or compromised decision-making capacity such that appropriate consent/participation is deemed difficult. Are concurrently participating in another clinical study. Are taking antiplatelet or anticoagulant medications, or have a history of epistaxis or other bleeding disorders (due to increased bleeding risk associated with self-collected nasal specimens). Historical In-Person Group Patients meeting the following will be excluded: After public disclosure via opt-out, expressed refusal to participate.
Design outcomes
Primary
| Measure | Time frame |
|---|---|
| Total medical cost per complete episode of influenza care, compared between the telemedicine and in-person groups. | — |
Secondary
| Measure | Time frame |
|---|---|
| 1) Interval from symptom onset to consultation (hours). 2) Patient-reported psychological burden measured by questionnaire. 3) Clinical outcomes after the consultation (e.g., complications, re-consultation). | — |
Countries
Japan
Contacts
Public ContactYasuhisa Tajima
Hamamtsu University School of Medecine Community Health & Preventive Medicine
Outcome results
None listed